Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 218, pseudogene (RNU6-218P) is a genomic sequence homologous to the functional U6 small nuclear RNA gene but is classified as a pseudogene. U6 snRNA itself is an essential noncoding RNA involved in pre-mRNA splicing as a core component of the spliceosome, but its pseudogenes such as RNU6-218P are generally non-functional remnants that do not encode active RNA and are not involved in post-transcriptional regulation or cellular signaling. The prevalence of multiple U6 snRNA pseudogenes in vertebrate genomes indicates historical duplication events but not active regulatory or therapeutic roles[3][5]. There is no evidence for disease involvement, direct protein-coding capability, or drug interaction for RNU6-218P.
None (pseudogenes like RNU6-218P are not targeted by drugs, do not encode proteins, nor modulate signaling directly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 218, pseudogene (RNU6-218P).